WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents

Saved in:
Bibliographic Details
Published in:Drug development research 1997, Vol.40 (2), p.144-157
Main Authors: ENSINGER, H. A, BECHTEL, W.-D, BIRKE, F. W, MENDLA, K. D, MIERAU, J, SPECK, G, TRÖGER, W
Format: Article
Language:English
Subjects:
Biological and medical sciences
Medical sciences
Neuropharmacology
Neuroprotective agent
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 157
container_issue 2
container_start_page 144
container_title Drug development research
container_volume 40
creator ENSINGER, H. A
BECHTEL, W.-D
BIRKE, F. W
MENDLA, K. D
MIERAU, J
SPECK, G
TRÖGER, W
description
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_2777477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2777477</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_27774773</originalsourceid><addsrcrecordid>eNqNjcFKAzEURUNRcGz9h7cQ1MVAkg5kprtBLC5cVlyWR_rSPslkhpdUqP68s_ADXN3NOecuVGV019bWdt2VqrR1tm7WnblRtzl_am1M07aV-vno38Bq08D2HR53GDP6yAdO9AQb6GESCiSUCmOMF0h0ljEB-sJfWDgdYThnj8KJPeBxTJwLhFGgnAiKEJZhdmEM0MfvE_FA8pDhwJkw00pdh_mQ7v52qe63L7vn13rCuRmDYPKc95PwgHLZW-dc49z6n9gv-hNQSw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>ENSINGER, H. A ; BECHTEL, W.-D ; BIRKE, F. W ; MENDLA, K. D ; MIERAU, J ; SPECK, G ; TRÖGER, W</creator><creatorcontrib>ENSINGER, H. A ; BECHTEL, W.-D ; BIRKE, F. W ; MENDLA, K. D ; MIERAU, J ; SPECK, G ; TRÖGER, W</creatorcontrib><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>CODEN: DDREDK</identifier><language>eng</language><publisher>Brisbane: Wiley-Liss</publisher><subject>Biological and medical sciences ; Medical sciences ; Neuropharmacology ; Neuroprotective agent ; Pharmacology. Drug treatments</subject><ispartof>Drug development research, 1997, Vol.40 (2), p.144-157</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2777477$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>ENSINGER, H. A</creatorcontrib><creatorcontrib>BECHTEL, W.-D</creatorcontrib><creatorcontrib>BIRKE, F. W</creatorcontrib><creatorcontrib>MENDLA, K. D</creatorcontrib><creatorcontrib>MIERAU, J</creatorcontrib><creatorcontrib>SPECK, G</creatorcontrib><creatorcontrib>TRÖGER, W</creatorcontrib><title>WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents</title><title>Drug development research</title><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neuroprotective agent</subject><subject>Pharmacology. Drug treatments</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqNjcFKAzEURUNRcGz9h7cQ1MVAkg5kprtBLC5cVlyWR_rSPslkhpdUqP68s_ADXN3NOecuVGV019bWdt2VqrR1tm7WnblRtzl_am1M07aV-vno38Bq08D2HR53GDP6yAdO9AQb6GESCiSUCmOMF0h0ljEB-sJfWDgdYThnj8KJPeBxTJwLhFGgnAiKEJZhdmEM0MfvE_FA8pDhwJkw00pdh_mQ7v52qe63L7vn13rCuRmDYPKc95PwgHLZW-dc49z6n9gv-hNQSw</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>ENSINGER, H. A</creator><creator>BECHTEL, W.-D</creator><creator>BIRKE, F. W</creator><creator>MENDLA, K. D</creator><creator>MIERAU, J</creator><creator>SPECK, G</creator><creator>TRÖGER, W</creator><general>Wiley-Liss</general><scope>IQODW</scope></search><sort><creationdate>1997</creationdate><title>WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease</title><author>ENSINGER, H. A ; BECHTEL, W.-D ; BIRKE, F. W ; MENDLA, K. D ; MIERAU, J ; SPECK, G ; TRÖGER, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_27774773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neuroprotective agent</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ENSINGER, H. A</creatorcontrib><creatorcontrib>BECHTEL, W.-D</creatorcontrib><creatorcontrib>BIRKE, F. W</creatorcontrib><creatorcontrib>MENDLA, K. D</creatorcontrib><creatorcontrib>MIERAU, J</creatorcontrib><creatorcontrib>SPECK, G</creatorcontrib><creatorcontrib>TRÖGER, W</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ENSINGER, H. A</au><au>BECHTEL, W.-D</au><au>BIRKE, F. W</au><au>MENDLA, K. D</au><au>MIERAU, J</au><au>SPECK, G</au><au>TRÖGER, W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents</atitle><jtitle>Drug development research</jtitle><date>1997</date><risdate>1997</risdate><volume>40</volume><issue>2</issue><spage>144</spage><epage>157</epage><pages>144-157</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><coden>DDREDK</coden><cop>Brisbane</cop><cop>New York, NY</cop><cop>Chichester</cop><pub>Wiley-Liss</pub></addata></record>
fulltext fulltext
identifier ISSN: 0272-4391
ispartof Drug development research, 1997, Vol.40 (2), p.144-157
issn 0272-4391
1098-2299
language eng
recordid cdi_pascalfrancis_primary_2777477
source Wiley-Blackwell Read & Publish Collection
subjects Biological and medical sciences
Medical sciences
Neuropharmacology
Neuroprotective agent
Pharmacology. Drug treatments
title WAL 2014 FU (Talsaclidine) : A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease: Challenges and opportunities for developing muscarinic receptor subtype-based therapeutic agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A07%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=WAL%202014%20FU%20(Talsaclidine)%20:%20A%20preferentially%20neuron%20activating%20muscarinic%20agonist%20for%20the%20treatment%20of%20Alzheimer's%20disease:%20Challenges%20and%20opportunities%20for%20developing%20muscarinic%20receptor%20subtype-based%20therapeutic%20agents&rft.jtitle=Drug%20development%20research&rft.au=ENSINGER,%20H.%20A&rft.date=1997&rft.volume=40&rft.issue=2&rft.spage=144&rft.epage=157&rft.pages=144-157&rft.issn=0272-4391&rft.eissn=1098-2299&rft.coden=DDREDK&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E2777477%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_27774773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true